Health system spending on disease and injury in Australia 2022–23, analyses Australia’s national health spending to provide additional detail about the people receiving care and the conditions and diseases being treated.
In this report, 2022–23 data is presented for each of the 17 Australian Burden of Disease Study (ABDS) groups and 220 conditions within these groups. Spending for three additional groups, well care, the treatment of risk factors and examination and observation NEC are also included. Spending is reported by area of expenditure, age group and sex. This report also includes comparisons with historical data back to 2013–14.
- Cat. no: HWE 102
Key findings
-
In 2022–23, cancer had the highest spending followed by cardiovascular diseases and musculoskeletal disorders
-
Spending on cancer more than doubled from 2013–14 to 2022–23 and has been the highest ranked disease group since 2014–15
-
The highest spending in 2022–23 was for injuries from falls, osteoarthritis, back pain and problems
-
Spending on cancer, cardiovascular diseases and musculoskeletal disorders accounts for around 1/3 of disease spending